About FDA
Number of foreign inspections completed in the month resulting in a category of classifications called OTHER
Measure was implemented starting January 1, 2010
Dictionary: The number of foreign inspections performed by foreign inspection cadres where one of the following three outcomes occurred: 1. Referred to Center (RTC): the Establishment Inspection Report has been referred to the appropriate Center for a final inspection cadre decision. 2. Blank: the inspection has been completed but the investigator has not yet reported [into the database] what cadre decision will be recommended. 3. Unendorsed Official Action Indicated (OAI): the investigator’s recommendation is that the cadre decision should be OAI but this recommendation has not yet been endorsed (reviewed and approved) by the investigator’s supervisor.
Fiscal Year - 2010
Measure was implemented starting January 1, 2010
| Time | Target | Number of Inspections |
|---|---|---|
| Oct 2009 | N/A | N/A |
| Nov 2009 | N/A | N/A |
| Dec 2009 | N/A | N/A |
| Jan 2010 | N/A | 0 |
| Feb 2010 | N/A | 0 |
| Mar 2010 | N/A | 0 |
| Apr 2010 | N/A | 0 |
| May 2010 | N/A | 0 |
| Jun 2010 | N/A | 0 |
| Jul 2010 | N/A | 0 |
| Aug 2010 | N/A | 6 |
| Sep 2010 | N/A | 24 |
FY 2010 Overall: 30
Percent of foreign inspections in a month resulting in an initial classification of OTHER
Fiscal Year - 2010
| Time | Target | Percent of Inspections |
|---|---|---|
| Oct 2009 | N/A | N/A |
| Nov 2009 | N/A | N/A |
| Dec 2009 | N/A | N/A |
| Jan 2010 | N/A | 0 |
| Feb 2010 | N/A | 0 |
| Mar 2010 | N/A | 0 |
| Apr 2010 | N/A | 0 |
| May 2010 | N/A | 0 |
| Jun 2010 | N/A | 0 |
| Jul 2010 | N/A | 0 |
| Aug 2010 | N/A | 10 |
| Sep 2010 | N/A | 45 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







